CDH1 and neoplasm: Eleven BC cell lines are annotated as “carcinoma”, “adenocarcinoma” or “ductal carcinoma”, with no detailed pathology report or molecular analysis of the corresponding clinical tumor specimens available, yet recent data show that they have key ILC genetic features, such as CDH1 mutation.